Title: R&I: Bipolar Disorder Market - Size, Share, Global Trends, 2014
1 Bipolar Disorder (Manic Depression) - Pipeline
Review, H2 2014
No of pages 129
Publish Date October 2014
2Description
This report provides comprehensive information on
the therapeutic development for Bipolar Disorder
(Manic Depression), complete with comparative
analysis at various stages, therapeutics
assessment by drug target, mechanism of action
(MoA), route of administration (RoA) and molecule
type, along with latest updates, and featured
news and press releases. It also reviews key
players involved in the therapeutic development
for Bipolar Disorder (Manic Depression) and
special features on late-stage and discontinued
projects. Global Markets Directs report features
investigational drugs from across globe covering
over 20 therapy areas and nearly 3,000
indications. The report is built using data and
information sourced from Global Markets Directs
proprietary databases, Company/University
websites, SEC filings, investor presentations and
featured press releases from company/university
sites and industry-specific third party sources,
put together by Global Markets Directs team. Drug
profiles/records featured in the report undergoes
periodic updation following a stringent set of
processes that ensures that all the profiles are
updated with the latest set of information.
3Scope of the Report
- The report provides a snapshot of the global
therapeutic landscape of Bipolar Disorder (Manic
Depression) - The report reviews key pipeline products under
drug profile section which includes, product
description, MoA and RD brief, licensing and
collaboration details other developmental
activities - The report reviews key players involved in the
therapeutics development for Bipolar Disorder
(Manic Depression) and enlists all their major
and minor projects - The report summarizes all the dormant and
discontinued pipeline projects - A review of the Bipolar Disorder (Manic
Depression) products under development by
companies and universities/research institutes
based on information derived from company and
industry-specific sources. - Detailed Report at http//www.reportsandintellige
nce.com/bipolar-disorder-manic-depression-pipeline
-review-h2-2014-market
4Reasons to buy
- Provides strategically significant competitor
information, analysis, and insights to formulate
effective RD development strategies - Identify emerging players with potentially strong
product portfolio and create effective
counter-strategies to gain competitive advantage - Develop strategic initiatives by understanding
the focus areas of leading companies - Identify and understand important and diverse
types of therapeutics under development for
Bipolar Disorder (Manic Depression) - Plan mergers and acquisitions effectively by
identifying key players of the most promising
pipeline - Devise corrective measures for pipeline projects
by understanding Bipolar Disorder (Manic
Depression) pipeline depth and focus of
Indication therapeutics.
5Table Of Content
- Table of Contents
- Introduction
- Therapeutics Development
- Early Stage Products
- AstraZeneca PLC
- Intra-Cellular Therapies, Inc.
- SK Biopharmaceuticals Co., Ltd.
- Product Description
- Get full TOC at http//www.reportsandintelligence
.com/bipolar-disorder-manic-depression-pipeline-re
view-h2-2014-market/table-of-contents
6 FOR MORE DETAILS
Visit us at
http//www.reportsandintelligence.com/bipolar-diso
rder-manic-depression-pipeline-review-h2-2014-mark
et
Stay With Us
5933 NE Win Sivers Drive,205, Portland, OR
97220United States
TELEPHONE Direct 1 (617) 674-4143 Toll Free
1 (855) 711-1555E-MAIL sales_at_reportsandintellig
ence.com